The investigators in the university of Umea in Sweden had shown that the length of telomeres in globules in patients recently diagnosised of the cancer of the breast is moored to the survival taxes. The study, published in the research of the cancer of the periodical, it was carried through by one equips of inquiry directed for professor Goran Roos in the department of medical biological science, pathology.

The study sample that the length of telomere in globules is associated with the prognostic for the cancer of the breast. The globules of the patients who you suffer from cancer in the study had had ones telomeres one in such a way longer of what those of the controls. It is interesting to write down that inside of the patients of the group of the tumor with telomeres longer (= more for much time of what the average length of telomeres) it had a prognostic significantly poor of what fz patient with telomeres shorter. This difference in the survival over all was considered in the patients with more advanced illness, that is, with bigger tumors and metstases in the local glands of lymph.

It is particular important that the length of telomere in these globules proved to be a marking prognostic that is independent of other marking known prognostics (so great of tumor, metstase of the tumor). That is this new biological marker seems to be able to more say us on the future prospects of the patients who you suffer from cancer of what the markers previously known can.

The tips of cromossomas, telomeres, are important for the genetic stability of our stacks. In normal stacks, telomeres is shortened each time that the stacks if divide, since the cancerous cells generally have the steady length of telomere. This stability helps to supply to cancerous cells the perpetual life. The length of telomeres of a stack is determined by the counterbalance of positive and negative factors, many of that are unknown.

But because the patients of the cancer of the breast with telomeres longer in normal globules have poor prognostics of what other patients are obscure presently. A number of communications is under the quarrel. A probable hypothesis is that the lengths of telomere of the patients are a reflection of presently unknown functions of the system of immune defense. The data not-published preliminary of equip of inquiry show that this biological marker can also supply the prognostic information other illnesses of the tumor. This makes still more important to understand the mechanisms behind the observed differences of the length of telomere.

The study it was executed in contribution with colleagues in the oncologia and medical clinics in the hospital of the Academic of the hospital and the Malmo of the university of Norrland. The study it understands 265 patients who had given samples of blood directly later that they were disgnostic with cancer of the breast and 446 controls.

Reference:

Svenson U, Nordfjll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, survival of the cancer of the breast of Roos G. is associated with the length of telomere in peripheral globules. Research 2008 of the cancer, published May 15.

Vetenskapsradet (the Swedish Advice of Research)
http://www.vr.se

To add an examination of the ultrasound of the election to the routine mamografia disclosed to 28 percent more cancers of what the alone mamografia. However, the additional examination of the ultrasound substantially increased the taxes of results of the false positive and unnecessary bipsias, in accordance with an American college of the study of the net of the latent image of radiology (ACRIN) published in the introduction May of 14, 2008 of the periodical of American Medical Association. The College of Medicine of Keck of the University of the California of the South one was one of 21 places of participation.

This study of ACRIN it registered 2,809 women in the risk increased for the cancer of the breast and the data of the research of 2.637 of these women were eligible for the analysis. The used criteria to determine increased a risk of the cancer of the enclosed breast: age of the participant of 25 years or the chests oldest, dense, bipsia atypical of the chest, previous staffs and/or or moderate familiar antecedents of the cancer of the breast. The study it was made to the direct possible financing of a new partnership of the confidential-public enters the foundation of Avon and the national institute for the cancer (the NCO), part of the national justinian codes of the health (NIH).

Forty women had been diagnosised with cancer of the breast inside of 12 months of the initial election. The alone mamografia disclosed 20 cancers (50 percent of all the detected cancers) for a tax of the detection of the cancer of 7.6 women for 1.000 selected women, even so a cancer was dismissed. The combination of mamografia more the ultrasound of the election disclosed 31 cancers (78 percent of all the detected cancers) for a tax of the detection of the cancer of 11.8 women for 1.000 selected women. Eight of the 40 cancers had not been seen with mamografia or ultrasound in the height of the initial screen, but they had been discovered later during the period of twelve months for a tax of three cancers lacked for 1.000 selected women.

The risk to incur an unnecessary bipsia due to a result of the examination of the false positive of the suplemental ultrasound of the election was increased equally substantially in this study. The alone mamografia alerted an unnecessary bipsia for one in 40 women in this study. The combination of election of the mamografia and the ultrasound alerted an unnecessary bipsia for one in 10 women, or four times more women who have an unnecessary bipsia.

In accordance with Pretty Hovanessian, M.D., associate professor of radiology in the College of Medicine of Keck of USC and main investigator for the study, of the place for women in the high risk of cancer of the breast, us we learn that the ultrasound finds cancers not considered for the mamografia. However, we equally learn that he has a tax falsifies-positive significantly higher associate with the addition of an examination of the ultrasound. This means that something suspicious estve seen in the ultrasound that I eat the result of a bipsia poured not to be cancer.

When arguing the suplemental option of the mamografia with the ultrasound of the election with the women, will be important to alert them on the increased risk to have a bipsia due to an examination of the false positive.

The department of radiology in the College of Medicine of Keck, lead for the chair of Edward department Grant, in M.D., was a leader in this important crtica research, it wrote down.

The society against the American cancer recently recommended definitive women in the risk raised for the cancer of the breast was selected very with latent image of magnetic resonance (MRI) beyond what the mamografia, and these results do not change this recommendation. The women who have election MRI do not need the ultrasound the election. The women who are in the increased risk, that if they are submitting to the mamogrfica election and they are not recommended currently for MRI, or for who available or she is not tolerated, can desire to consider to add the ultrasound of the election.

The women must speak with its doctor on its profile of risk of the cancer of the breast and if an examination of the ultrasound of the suplemental election to the mamografia could be beneficial, grocery in the mind of the potential for a false positive result and an unnecessary bipsia. Presently, it has an limited source of trained staffs and the easinesses that offer the ultrasound of the election. The women equally must consult its safe from a health regarding the covering for options of the election of the cancer of the breast. An annual mamograma is recommended still: nor MRI nor the ultrasound are meanings to substitute the mamografia.

The study it continues to follow participant to examine the potential benefit of the routine annual election of the combination of the mamografia and the ultrasound.

University of the California of the South

A new approach esteem the growth of tumour based in results of the election of the chest of almost 400,000 women is open periodical of the access of the central office today published of BioMed, searches of cancer of the chest. This new model can also esteem the ratio of cancers of chest that is detected in the election (sensitivity of the test of the screen). It supplies a new approach simultaneously esteem the tax of growth of cancer of chest and the ability of the election of mammography to detect tumours.

The results of the study show that the taxes of growth of tumour vary consideravelmente between patients, with generally slower taxes of growth with increasing age in the diagnosis. To understand as tumours they grow is important in the planning and the evaluation of programs of election, clinical experimentations, and studies epidemiological. However, the studies of taxes of growth of tumour in the peoples had been based thus distant on selected samples mainly small e. Now, Harald Weedon-Fekjr of the department of the etiological research, the register of cancer of Norway and the colleagues had developed a procedure esteem new to follow the growth of tumour in a very great population of the patients of cancer of enclosed chest in the Norwegian program of election of cancer of chest.

The investigators had applied its model to the incidence of cancer and data of the measure of tumour of 395.188 women aged between 50 and 69 years old. They had found that the growth of tumour varies consideravelmente between subjects. Approximately one in twenty tumours fold in the size inside only on one month of 10 20mm, when the similar numbers had made examination of more than six years to come to this size. The 20 millimeters in the diameter had esteem the average moment for one tumour to fold in the size of 10 are 1,7 year.

“it has enormous implications for the sensitivity of programs of election” Weedon-Fekjr of cancer of chest explains. “we find that the sensitivity of the test of the screen of mammography (STS) increases acutely with size increased of tumour, as if could wait. The taxes of the detection are only 26% for one tumour of 5 millimeters but they increase 91% a time that one tumour is 10 millimeters in the size.” The team compared its model with the previously used model of Markov for the progression of tumour, and almost found its power predictive to be two times more accurate than the model of Markov, in the addition to directly supply the on new estimates to the size of tumour.

The article was adaptou today for Medical Notice of the release of the original press.

1. Growth of the tumor of cancer of chest esteem with the data of the election of mammography
Harald HWF Weedon-Fekjaer, Henry BHL LindqvistBo, odd ST TretliOlai OOA Aalen, of Lars Johan LJV Vatten and Steinar
Research of cancer of the chest (in the press)
Available article in the Web site of the periodical: http://breast-cancer-research.com/
All the articles are available free of the load, in accordance with the open politics of the access of the central office of BioMed.

2. The research of cancer of the chest is international a high quality, periodical pair-coats. The research of cancer of the chest publishes the original research, revisions and commentaries in all the areas of excellent biology and medicine when cancer of chest, including normal biology mammary of the gland, with special emphasis in the base genetic, biochemical, and cellular of cancer of chest. All the published articles of the research in the periodical are open access; commentaries, the revisions and the reports on two years old are free to reach, before this that require a subscript. The periodical is edited by Dr. Lewis Chodosh (U.S.A.) and has a factor of the impact of 4.16.

3. The central office of BioMed (http://www.biomedcentral.com/) is a house publishing in independent line committed to supply the immediate access without load to the research that biological and medical pair-magazine publishes. This commitment is based on the sight that the open access to the research is essential to the fast and efficient communication of science.

Source: Charlotte Webber
Central officeBioMed

The patients of cancer of chest can receive radiotherapy in a lower total dose, given in less, bigger administrations, when keeping the similar control of the tumor and when creating few adverse side effects of that the current therapy. These conclusions come of the standardisation of the Joined Kingdom of the experimentations and the B of radiotherapy of the chest (the B STARTS and), and had been set free March in 19, 2008 in oncology of lancet and lancet respectively.

The programming international standard of radiotherapy to cancer it of chest in advance manages 50 leached ashes (Gy) of the total of the radiation, separate in 25 2.0 small fractions of Gy on five weeks. Specialists do to cancer has believed for much time that, when delivered in less, the fractions biggest, a lower total dose could be so safe and efficient how much this standard.

The group collaborative of the experimentations of the START, including the professor John Yarnold, institute of the research of cancer and the real hospital of Marsden, the Sutton, the Surrey, the Joined Kingdom, and professor Judith Bliss, clinical experimentations and statistics unit, institute of the research of cancer, Sutton, Joined Kingdom, and colleagues of 35 BRITISH centers of cancer investigated this option. The study fz examination of ten years, and he was financed jointly by the research of cancer Joined Kingdom, by the BRITISH advice of medical research, and by the BRITISH department of the health.

HE STARTS was understood It of 2.236 women with cancer in advance of chest in 17 different centers in the Joined Kingdom. They had been attributed aleatria, after the preliminary surgery to one of the following groups:

• 34% (749 women) to receive 50 totals from Gy in 25 2.0 fractions of Gy each one, dosage total the most raised and the international standard;
• 34% (750 women) to receive 41,6 totals from Gy in 13 3.2 fractions of Gy each one, dosage total intermediary;
• 33% (737 women) to receive 39 totals from Gy in 13 3.0 fractions of Gy each one, dosage total lowest.

The treatment was managed in all the groups on a period of five weeks. The women had been considered eligible if they were on 18 years of age, they did not have reconstruction surgical immediate, and were available for follow.up. Endpoints of the experimentation was: relapse of the tumor, that was defined as reappearance of cancer in the places that irradiated; all the effect of the treatment in the normal one or “cancer exempt” weaveeed; e effect in the quality of life for the patient.

Later that one follow.up medium of 5.1 years, relapse of the tumor in five years was 3,6% for the the most raised total group of dosage (50 Gy), 3,5% for dosage total intermediary (41,6 Gy) and 5,2% for grou it total lowest of dosage (39 Gy.) The behind adverse effect and the local taxes of relapse of the tumor for dosages total highest and intermediate were similar, that in the dose lowest differnce absolute could vary of 1.3% more better 2,6% worse in the lowest group of the dose. Self-assessments patient as well as photographic examinations had indicated that it had lower taxes of delayed adverse effect in the lowest group of dosage of teh of that in the most raised.

In the conclusion to the study of the START, the authors indicate that this modification to regimen international standard could have the promise: “a lower total dose (41

The university of the institute of cancer of Pittsburgh (UPCI) announced the establishment of Frieda G. and the program of research of Saul F. Shapira BRCA Cancer. BRCA 1 and 2 are two genes that, when mutated, increase dramtica the risk of cancers of the chest, prostate, ovarian and pancreatic.

“I am excited on the addition of this program of research the UPCI,” I said Ronald Herberman, M.D., director of UPCI and the university of centers of cancer of the medical center of Pittsburgh (UPMC). “more than we learn on these mutations, better the possibility we have that to whiten patients high-risk and to find ways innovative to reduce its risk of cancer.”

The women who possess one or another one mutation have a risk of a the 80 life of 50 percent to develop cancer of chest, and the illness progresses more quickly of the one than in the individuals without mutations. The connoisseurs esteem that as much as while a rejection of each 345 peoples in the United States loads one mutation of BRCA, but for individuals of the descending jewish of Ashkenazi (European oriental), the number is approximately one in 40.

These mutations had been on first with a risk increased of cancer of chest in the women, but they also increase the risk for others cancers. the men and the women can load mutations genetic, that half they can be passed the children of one or another father.

The S. of David and the Karen the Shapira Foundation had committed one $1 million initial for the program, having structuralized the gift as a concession combining to raise one $1,5 million additional of the individuals and the foundations. UPMC is combining these gifts in a dollar-for-dollar base, for a total objective of $5 million.

“currently, burden of cancer cost to each one approximately $936 Americans the one year,” said the Dr. Herberman. “the research supporting of the budget of the national institute of cancer only reaches $21 for the American annually. To finance the research of cancer promising, the investigators need other ways of the sustentation. A gift as this that we receive from the foundation of Shapira, complemented for deep of community and UPMC, will go a long way to support this important program.”

The article was adaptou today for Medical Notice of the release of the original press.

Already, the local leaders of the community and foundations had contributed $850,000 for the objective fundraising. To more learn on the research groundbreaking that this money will support, to satisfy estala here.

Established in 1984, the university of the institute of cancer of Pittsburgh seated in a national institute of cancer (NCI) - center detailed assigned of cancer in the time well record (per 1990). UPCI, the only center of cancer in Pensilvnia occidental person with this assignment of the elite, more than serve the population of the region of 6 million. Presently, UPCI receives a total from $154 million in concessions of the research and is 10o thick in financing of the NCI.

Source: Courtney McCrimmon
University of the medical center of Pittsburgh

When a form of cancer that it starts in the ducts of the milk of the chest invades the fabric neighboring to spread to other parts of the body, the cause meets not in the stacks same they of the tumor but in a group of abnormal the surrounding stacks that in accordance with make with that the walls of the duct if spoil as an oxidated tubing, a new study lead by investigators of the institute of Dana-Farber Cancer.

The discovery, told in the introduction May of 6 of the stack of cancer, can lead to the election tests to determine if the illness — known as ductal carcinoma in situ, or DCIS — is probable to spread beyond the ducts, based in abnormalities genetic in the stacks in the lining of the ducts. E adjusts the period of training for the treatments that, whitening these abnormalities, they support above of the walls of the duct and keep contained cancer.

the “women whose DCIS invaded the ducts are known to have a greater possibility of the metastasis, or the illness spreading. But not estve opened that causes the transistion of cancer located to the illness invasive, “in accordance with the senior author of the study, Kornelia Polyak, MD, PhD, of Dana-Farber. “this study it demonstrates that one in DCIS of the chest, and potential in others cancers that they originate in fabrics of the duct, the reply can meet in microenvironment of the tumor — the stacks and the fabric that surrounds cancer.”

DCIS almost expects to be diagnosised in 53,000 women in the United States this year. When detected and removed cirrgica before it will have a possibility to spread, the illness is almost always curable. One does not know how much of these cancers if would transform to cancer of chest invasive if they will not be treated, but the studies suggest that the majority of them eventually.

The investigators had initially thought of that DCIS could become invasive in consequence of the changes genetic in the stacks of cancer. When they had examined the activity of the gene in stacks immobile of DCIS and in that they had spread them, however, it did not find no difference significant. This lead to it to consider microenvironment of the stack.

Polyak and its colleagues had focused in the stacks myoepithelial, that the part of the form of the lining of the ducts of milk and is involved in the development of the chest, as.well.as to hinder the growth and invasiveness of some stacks to cancer. To study that paper, if to existerem, these stacks played in DCIS, the investigators had worked with an especially projected line of the known stacks as MCFDCIS.

When injected in laboratory animals, the stacks of MCFDCIS they had given form to the fabric of DCIS-like that if became tumors invasive, supplying a good model of what human being happens in the illness. When the investigators had injected myoepithelial MCFDCIS and stacks in the rats, tumors of DCIS had been arisen, but they had been confined to the ducts. When they had injected stacks of MCFDCIS and fibroblasts — stacks found in ducts of milk and the other fabric connective — tumors resultant of DCIS had broken in the walls of the ducts.

“these findings had made the free space to it that fibroblasts the growth and the invasion of the tumor promote, and the normal stacks myoepithelial suppress it,” Polyak observes. But when determined genes in the myoepithelial layer if they become inferiors or overactive, the layer breaks for low e disappears, allowing stacks of the tumor to run away itself.

To identify that genes are affected and that causes its level of activity to move, team of Polyak examined the activity of the thousands of the genes in stacks myoepithelial and DCIS using (serial analysis of the expression of the gene) advanced CAUTIOUS technology. When tumors of DCIS infringes in the lining of the ducts, the level of activity of diverse genes myoepthelial of the stack is abnormal — specifically the TGF beta, Hedgehog, and genes p63 as.well.as the genes that help the stacks myoepithelial to pierce to the stacks of the “bilge” in the exterior layer of the ducts. The effect is one cacaphony of erratic signals and the activity haywire that it hinders that the stacks myoepithelial entirely ripen and give to form to an efficient barrier the DCIS.

“we find one interplay constant, complex of the signals between these genes, both inside of the stacks myoepithelial same they, and between stacks myoepithelial and its neighbors,” Polyak says. “the DCIS presence cause the test standard of the signals to move significantly, turning myoepithelial the normal development stacks. The stacks myoepithelial do not differentiate “- - act entirely as ‘ gatekeepers ‘ true for DCIS –” to lead to disappearance of the myoepithelial layer and to the start of the invasion of the tumor.”

The discovery suggests that making the sweepings of the fabric myoepithelial for abnormalities in these genes keys, the doctors can be able to identify that women with DCIS have the greatest risk of the propagation of cancer, say Polyak, that is also a professor of associate of the medicine in the medical school of Harvard. It also supplies white numerous the future drugs aimed at restoring the normal counterbalance of the signals between these genes.

“our results detach the importance of microenvironment in the progression of the tumor of the chest,” comments of Polyak. “and they suggest that the therapies that whiten the interactions of stacks of the tumor with its arredors can offer a better way to inhibit the progression of the tumor of that those that they focus in the stacks epithelial of the alone tumor.”

The article was adaptou today for Medical Notice of the release of the original press.

The author of the linking of the study is minimum Hu, PhD, of Dana-Farber. The co-authors are June Yao, PhD, Haiyan Chen, PhD, Erica Bauerlein, Daniel Carrasco, MD, PhD, William Hahn, MD, PhD, and Rebecca Gelman, PhD, of Dana-Farber; Stanislawa Weremowicz, PhD, and Andrea Richardson, MD, PhD, of Brigham and hospital of the women; Danielle Carroll, PhD, of the medical school of Harvard; Sheila Violette, PhD, of Biogen-Idec of Cambridge, Mass.; Tatiana Nikolskaya, PhD, and Yuri Nikolsky, PhD, of GeneGo, Incorporation, of St. Joseph, Mich.; Craig Allred, MD, of the school of the university of Washington of the medicine; Mine Bissell, PhD, of the laboratory of the national one of Lawrence Berkeley; e Stuart Schnitt, MD, of the medical center of Beth Israel Deaconess.

To finance for the study was supplied by the national justinian codes of the health, by Susan G. Komen Foundation, and by Biogen-Idec.

The institute of cancer of Dana-Farber (http://www.dana-farber.orgwww.dana-farber.org/) is a branch office teaching main of the medical school of Harvard and is enters the main centers of the research and the care of cancer in the United States. It is a member establishing of the center of cancer of Dana-Farber/Harvard (DF/HCC), assigned a center detailed of cancer for the national institute of cancer.

Source: RayRobbin
Institute Of The CancerDana-Farber

The patients of cancer of chest who have one history previous in the way and disorders of anxiety are in a raised risk not to try disorder posttraumatic of stress after its diagnosis, new research suggest.

A study of 74 patients of cancer of chest in the medical center of university of state of Ohio he found that 16 percent of them (12 women) had suffered from PTSD 18 months after the diagnosis.

The women with PTSD were more than two times that more probably patient of cancer of chest without disorder to have suffered from disorders preceding in the way such as depression before the diagnosis cancer. They were also more than three times more probably to have tried disorders of anxiety.

“what she is original on patients of cancer of chest with PTSD she is that she has had already this stroke double of disorders of the anxiety and in the same way before started the diagnosis,” said Barbara Andersen, co-author of the study and professor of psychology in the university of state of Ohio.

“thus when they are in a new situation that is much anxiety that it provokes - disgnostic and treatment of cancer - it is not surprising that they are in the risk to develop PTSD.”

Findings suggests that the doctors must select patients of cancer of chest recently diagnosised for disorders passed in the way, it had said. Those that they have histories of disorders in the way and anxiety can they need the aid the end to prevent PTSD. However, the results also show that the majority of patients of cancer of chest is not in the risk for PTSD.

Andersen lead the study with the Dourado-Kreutz manager, physician of Deanna of the research in the unit of cardiovascular clinical research of the state of Ohio, and the Rebecca Shelby, a student graduated of the previous state of Ohio now the medical center of the duke University.

Its study he appears in the introduction of April 2008 of the periodical of stress traumatic.

Beyond to the women who had had PTSD, others 20 percent (15 women) had had “subsyndromal” PTSD, meaning that they had tried PTSD symptoms significant, but not in the level of those with the full diagnosis.

The patients with subsyndromal PTSD were more probable of the one than others to have had disorders in the way, but compared with those that had had full PTSD, were less probable not to suffer from disorders of anxiety, said Andersen.

Findings had shown that after the alcohol and the substance the on abuse estve also to the symptoms posttraumatic of disorder of stress. Approximately one tero of the women with PTSD had had after history of the abuse or the dependence of alcohol/substance, compared with a fifth of women subsyndromal one and one tenth of the women with no PTSD.

One another edition for the women who had had PTSD - in comparison to those with subsyndromal PTSD and those with no PTSD - was one history of life events traumatic, the joined study. For the example, the half of the PTSD patients told the attack physically or to have been abused in its lives, compared with less than 17 percent of the women in others two groups.

Although the women with symptoms subsyndromal fared generally more better of the one than those with full disorder, in women of some cases in both the groups faced difficulties dealing significant. The women in the two groups were almost four times more probably of the one than those with no PTSD to say them were incapable to work because of the emotional affliction (42 percent of the group of PTSD, 40 percent of the subsyndromal group, and 11 percent of those with no PTSD.)

“that it is an enormous difference, and it shows to the impact Real-life that the PTSD symptoms can have in some patients of cancer of chest,” said Andersen.

When the study to suggest the majority of patients of cancer they are not in the risk for PTSD, disorders said Andersen in the way are one another substance.

“I think that depression is the mental condition of the health that needs the majority attention until the treatment of patients of cancer of chest, exactly more thus of the one than PTSD” it said. “that it is the direction our research is going, and we are working to develop an intervention to deal with patients cancer with depression.”

The article was adaptou today for Medical Notice of the release of the original press.

The research was supported by concessions of the American society of cancer; Society Company-American Grant of cancer of Longaberger for the research of cancer of the chest; Institute De Medical Pesquisa Of the Army of United States; National institute of the mental health; National Institute Of The Cancer; the institute of cancer of Walther; e the center detailed of cancer of the state of Ohio.

Writing for Jeff Grabmeier

Source: Barbara Andersen
UniversityEstadoOhio

The scientists had made a significant discovery that clarified an event key previously badly understood in the progression of cancer of chest. The research, published for Stack To pressure in the introduction of May of the stack of cancer of the periodical, detaches the importance of microenvironment in the progression regulating of the tumor of the chest and suggests that it can highly be beneficial to consider the therapies that they do not focus solely in the stacks of the tumor but it is also whitened to surrounding fabrics.

The progression of cancer of chest starts with proliferation epithelial abnormal person who progresses in the located carcinoma, called ductal carcinoma in situ (DCIS); carcinoma invasive; e eventually, illness metastatic. DCIS is believed to be a precursor to the ductal carcinoma invasive, but to stand molecular detailed studies to compare DCIS and the carcinomas ductal invasive had not relieved tumor-period of training-specific signatures genetic. “these studies had focused mainly in the stacks epithelial of the tumor and they had not explored the paper of microenvironment in the expression of the tumor,” says the Dr. Kornelia Polyak of the author of the study of the linking of the institute of cancer of Dana-Farber in Boston.

The Dr. Polyak and colleagues explored the participation of microenvironment in the progression of the tumor examining the stacks myoepithelial, that are known to play a critical paper in the development mammary of the gland and to have negative effect in the growth and the invasion of the stack of the tumor. To study interactions between stacks of to cancer of chest and stacks myoepithelial, investigators had used model human of tumor MCFDCIS called progression chest, that it gives form lesions of DCIS-like that they spontaneously progress to tumors invasive, one pathology that prxima to the illness was resembled human being.

Using this model, the investigators had observed that the normal stacks myoepithelial suppress the growth and the invasion of the tumor in the absence of detectable changes genetic in the stacks epithelial of the tumor. They had been on identifying to a intricate net that involve TGFb, Hedgehog, adhesion of the stack, and p63 that it seems to play a critical paper in differentiation myoepithelial of the stack. Perturbation of mediators keys of these pathways signaling lead to a myoepithelial loss of stacks and a progression to the invasion.

“here, we show that an event key of the progression of the tumor is disappearance of the myoepithelial layer of the stack due to differentiation myoepithelial defective of the stack regulated for signals of intrinsic and of microenvironment. Thus, the stacks myoepithelial can be considered gatekeepers of the one in situ to the transistion invasive of the carcinoma; to understand pathways that they regulate its differentiation can open venues new for the therapy and the prevention of cancer, “offers the Dr. Polyak.

The article was adaptou today for Medical Notice of the release of the original press.

The investigators include minimum Hu and Yao June of the institute of cancer of Dana-Farber and the medical school of Harvard in Boston, milliampere; Danielle K. Carroll of the medical school of Harvard in Boston, milliampere; Stanislawa Weremowicz of the hospital of Brigham and women and of the medical school of Harvard in Boston, milliampere; Haiyan Chen of the institute of cancer of Dana-Farber and the school of Harvard of the public health in Boston, milliampere; Daniel Carrasco of the institute in Boston, milliampere of cancer of Dana-Farber; Andrea Richardson of the hospital of Brigham and women and of the medical school of Harvard in Boston, milliampere; Shelia VioletteBiogen-Idec in Cambridge, milliampere; Tatiana Nikolskaya and Yuri Nikolsky de GeneGo, Incorporation in St. Joseph, MI; Erica L. Bauerlein and William C. Hahn of the institute of cancer of Dana-Farber and the medical school of Harvard in Boston, milliampere; Rebecca S. Gelman of the institute of cancer of Dana-Farber and the school of Harvard of the public health in Boston, milliampere; Craig Allred of the school of the university of Washington of the medicine in St. Louis, Me; Mine J. Bissell of the national laboratory of Lawrence Berkeley in Berkeley, CA; Stuart Schnitt of the medical medical center in Boston, milliampere of the school and Beth-Israel Deaconess of Harvard; e Kornelia Polyak of the institute of cancer of Dana-Farber and the medical school of Harvard in Boston, milliampere.

This work was supported in the part for concessions of NIH, DOD, and ACS, for one fellowship of Susan G. Komen Foundation, for Biogen-Idec., and pharmaceuticals of Novartis, Inc..

Hu et al.: “regulation in Situ to the transistion invasive of the carcinoma of the chest.” Publishing in the stack of cancer 13, 394-406, May 2008. DOI 10.1016/j.ccr.2008.03.007 http://www.cancercell.org/

Source: Cathleen Genova
The Press Of The Stack

A preliminary analysis of research ongoing suggests that the women high-risk with cancer of chest who do not have one mutation BRCA1/2 can face a greater possibility to develop as to cancer of chest of that she thought previously. With the risk increased of cancer in these women, must biopsy of the knot of the sentry be considered in the height of mastectomy prophylactic, and as it can after the women best be advised these findings?

The increased risk to develop cancer of chest is understood already for the women with the illness who test the positive for a BRCA1 or one mutation 2. Many of these women choose to have cirrgica its breast(s) removed (mastectomy prophylactic) to reduce its risk to develop cancer of chest or developing as to cancer of chest the paper of biopsy of the knot of the sentry it remains controversial in this group.

“we know more on advising to the women regarding mastectomy prophylactic we will have one mutation of BRCA,” we say Shawna C. Willey, MD, FACS, a member of the program of cancer of chest in the center detailed of cancer of Lombardi and director of the center of the health of the chest of Betty Lou Ourisman in the hospital of the university of Georgetown. “in the women high-risk that they have cancer but they do not have one mutation known, us recommends generally that the risk to develop as to cancer in the same one or the opposing chest is lower of the one than is for the women who test the positive for one mutation. This the most delayed analysis has them re-thinking our approach.”

Willey, incoming president of the American society of surgeons of the chest, is the author of the linking of the study presented in the annual meeting of the society in New York City.

The study it included the women in a familial register of cancer in Lombardi who had been registered between 1998 and 2007. Participants of the register percent had had one but a probability of 10 to load one mutation BRCA1/2 based on history personal or of family of cancer. Cohort for the study included 119 women. 74 women had had one mutation of BRCA (group 1) and 45 did not test the positive for mutation (group 2). The women in malignancies known already states with of group 2 and had had to test genetic preoperative. All the women opted to have one mastectomy to remove its chest affected (group 2) or surgery to remove both the chests (both the groups). All had the both the removed chests, but in the group 2 they had had all one mastectomy prophylactic unilateral.

“we examine the tax of malignancies occult in both these groups of the women in specimens prophylactic of mastectomy,” Willey we explain. “what we find he was interesting. He more highly had a presence of the one than foreseen of the illness in the women who had not tested the positive for one mutation of BRCA.

“the tax more raised of cancers occult in group 2 can be because all malignancies known contralateral states with, but this study they support the use of mastectomy prophylactic while an option for these women while it is for that they have one mutation of BRCA,” says Willey.

Willey writes down that the studies you add must direct to the paper of biopsy of the knot of the sentry for the women high-risk that they are receiving mastectomy prophylactic.

“we need a better understanding the incidence of cancer in these women to help to determine the necessity for biopsy of the knot of lymph of the sentry in the height of mastectomy, uniform in the patients where mastectomy is entirely prophylactic,” we say Willey. “it has involved risks and serious side effects with biopsy of the knot of the sentry. We will need to find a counterbalance between offering to the appropriate care and the on-treatment of these women.

“the trend in this study detaches the importance to advise to all the women high-risk on its risk to develop one other to cancer when considering surgical options including biopsy of the knot of the sentry.”

The article was adaptou today for Medical Notice of the release of the original press.

On The Detailed Center Of The CancerLombardi

The center detailed of cancer of Lombardi, part of the medical center of the university of Georgetown and the hospital of the university of Georgetown, searches to improve the diagnosis, the treatment, and the prevention of cancer with innovative the basic and clinical research, the patient care, the instruction of the community and to exceed them, and the training of specialists of cancer of the future. Lombardi is one of 39 centers only detailed of cancer in the nation, as assigned for the national institute of cancer, and only in Washington, C.C., area. For more information, http://lombardi.georgetown.edu goes/.

On The Medical Center Of The University Georgetown

The medical center of the university of Georgetown is recognized a medical center academic international with a mission three-part of the research, the education and the care of the patient (with our partnership with health of MedStar). Our mission is carried through with a strong emphasis in the public service and one dedication to the principle of catholic, jesuit of personalis of the cure — or to the “care of the entire person.” The medical center includes the school of the medicine and the school of studies of the cares and the health, both thick ones national, the detailed center world-world-renowned of cancer of Lombardi and the organization of graduated research biomedical (BGRO), the 60 rest percent to finance sponsored of the research of the university.

Source: RammerKaren
Medical Center Of The UniversityGeorgetown

Aprova0 received from Cytori (NASDAQ:CYTX) to start its europia connecting rod and stack-enhanced study regenerative of reconstruction of the chest in the patients of cancer of chest whom if they had submitted to mastectomy partial. This is a study of the appointed post-market as RESTORE II. Currently, it does not have none technique reconstructive generally accepted for partial patients of mastectomy despite the fact that the therapy conserving of the chest is practical standard in the treatment of the women with cancer of chest worldwide.

In this study, the loss of the fabric that reconstructed with proper fabric results of mastectomy partial fat person of the patients (adipose), that it will be enhanced with its connecting rod regenerative adipose-derivative and stacks. This procedure is consulted as to reconstruction stack-enhanced. The stacks in RESTORE II will be made available in the height of the surgery using the system of Celution(R) 800 of Cytori.

The preliminary objective is to get the European reimbursement for reconstruction stack-enhanced using the system(R) of Celution 800 measuring the quality key of improvements of the life in the patients of cancer of chest who desire reconstruction. Up to 70 women they will be registered in six clinical centers in the Joined Kingdom, in the Italy, the Spain, and the France. Endpoints preliminary will be patient satisfaction and of the doctor with functional results and cosmetic in six and 12 months after the surgery. The objective of Cytori is to finish the register before the end of March 2009.

“RESTORE II is important to advance options reconstructive for women with cancer of chest,” said professor Emmanuel Atrasar, main investigator of the study and head of the plastic and the surgery of Reconstructive in the center of cancer of Leon Brard in Lyon France. “a successful study the availability of this therapy to the partial patients of mastectomy in Europe must broaden.”

“unhappyly few options are available to the women desperate for the surgery reconstructive that it follows mastectomy partial due to the effect of radiotherapy adjuvant,” said Mrs. Eva Weiler-Mithoff, surgeon in the real infirmary of Glasgow, and investigator of the linking for the BRITISH place of the study. “the fabric adipose enriched with connecting rod and regenerative stacks represents a new approach that we let us believe allows to the retention predictable of graft.”

“my clinical experience ongoing that it uses the system of Celution(R) 800 of Cytori in reconstruction of the chest has stimulated very,” said the professor Claude Calabrese, the professor of associate of the surgery and the investigator of the linking in the university of the hospital of Florena. “the preliminary results authorize an inquiry additional as the part of widest, study of RESTORE II of the post-market.”

Endpoints secondary includes six and evaluations 12-month of the volume and the form of the chest through magnetic the latent image of resonance (MRI) and improvement in pigmentation of the skin. The study it will evaluate the patients who if have submitted its last treatment to little 12-months of the chest previously and are free return.

“the system(R) of Celution 800 is what it makes to this an efficient one, reproducible, procedure of bedside,” said the Dr. marc H. Hedrick, president of Cytori. “Cytori customized this system to supply specific output stack to reconstruction of the chest, to be easy to use doctors and hospitals, and to be affordable. We believe that this mixture of the attributes combined with our objective of the reimbursement could full a tremendous necessity of the patient and the market.”

The fat, known medicamente as the fabric adipose, is the known source richest of the body of regenerative stacks. the regenerative stacks Adipose-derivatives beyond include stacks of connecting rod of the adult to other important types of the stack that had been shown pre-clinically to improve the retention of the fabric comparative the non-stack-enhanced transferences of the fabric. These results had been confirmed in clinical studies doctor-initiates.

On Cytori

The objective of Cytori (NASDAQ:CYTX) is to be the global leader in the regenerative medicine. The company is dedicated to supply patient with the new options the surgery reconstructive, to develop treatments for the cardiovascular illness, and to deposit the connecting rod of the adult of the patients and regenerative stacks. The system(R) of Celution 800 is being introduced in Europe in the market reconstructive of the surgery when the system(R) of Celution 900 will be launched in Asia-Pacific for cryopreserving proper connecting rod and regenerative stacks of a patient. The clinical experimentations are ongoing in the cardiovascular illness and are gliding for degeneration spinal of the gastrointestinal record, disorders, and other medical necessities of unmet. http://www.cytoritx.com

Cautionary indication Regarding the Indications For Diante-Olhando

This release of the press includes ahead-to look at the indications regarding the events, of the trends and the prospects of the business, that can affect our future results if operating and financial position. Such indications are citizens to the risks and the uncertainties that could make with that our real results and financial position differ materially. Some of these risks and uncertainties include ours history of losses operating itself, the necessity for a additional financing, the uncertainties regulatory regarding the collection and the results of, given physicians, dependence in the described performance of the third party, and other risks and uncertainties under of “the factors risk” in fillings of commission of seguranas and exchange of Cytori. We do not assume no responsibility to bring up to date or to revise nenhumas indications for ahead-looking at to reflect events, trends or circumstances after the date where they are made.

http://www.cytoritx.com